Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
| Title | An Open-label, Multicenter Phase 1 Study to Characterize the Safety, Tolerability, Preliminary Antileukemic Activity, Pharmacokinetics, and Maximum Tolerated Dose or Pharmacological Active Dose of BAY2402234 in Patients With Advanced Myeloid Malignancies |
|---|---|
| Disease/Condition | Myelodysplastic Syndrome (MDS),Leukemia,Cancer,Neoplasms |
| Description | |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | Amit Verma, MD |
| Contact Name | Apoorva Talanki |
| Contact Email | atalanki@montefiore.org |
| Protocol Number | 18-06-93-01 |
| Inclusion/Notes | This Information was obtained from ClinicalTrials.gov |
| Status | Active/Enrolling |
| Adult Clinical Trial | Yes |
| Pediatric Clinical Trial | No |
| Sub-Specialty | Acute Leukemia |
| Adult, Pediatric, Both | Adult |
